We also cultured PBMCs collected from untreated iGRAN-low (<14%) and iGRAN-high (≥14%) CMML patients for 4 days with anti-CD3 and anti-CD28 antibodies for T cell activation. Here, CD28 is linked to chronic myelomonocytic leukemia.